Company registration number 02049362 (England and Wales)
FLUOROCHEM LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
FLUOROCHEM LIMITED
COMPANY INFORMATION
Directors
L D Jones
D Birch
Secretary
D Birch
Company number
02049362
Registered office
Unit 14 Graphite Way
Rossington Park
Hadfield
Derbyshire
SK13 1QH
Senior statutory auditor
Tracey Connor BSc FCA
Auditor
Chadwick & Company (Manchester) Limited
Chartered Accountants
Statutory Auditors
Capital House
272 Manchester Road
Droylsden
Manchester
M43 6PW
Business address
Unit 14 Graphite Way
Rossington Park
Hadfield
Derbyshire
SK13 1QH
FLUOROCHEM LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of income and retained earnings
7
Balance sheet
8
Notes to the financial statements
9 - 18
FLUOROCHEM LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -
The directors present the strategic report for the year ended 31 December 2024.
Review of the business
The results for the period and the financial position at the end of the period were considered satisfactory by the directors.
Sales in the period have risen despite the continuing impact of Brexit and increased inflationary pressures impacting both the UK and worldwide economies. The increase in sales is compounded by increasing sales in the group's fellow subsidiary undertaking, Fluorochem EU Limited (Ireland).
Principal risks and uncertainties
The directors have identified the key risks faced by the company and have put systems in place to mitigate these risks.
The company is engaged in the sale of chemicals to a wide variety of markets and is therefore exposed to the risk of reduction in economic growth in these markets.
The company's performance will be affected by movements in exchange rates, given that purchasing activity takes place in both the US Dollar and the Euro.
The company is subject to a number of laws and regulations including environmental and health and safety, which could result in additional costs related to compliance.
The directors consider that the company's exposure to credit, cash flow and liquidity is minimal given the nature of the business and balance sheet position.
Development and performance
The market in which the company operates remains competitive. The directors however expect the company's turnover and profitability to improve in the foreseeable future.
The continuing investment in research and development and improving the stock information system will assist in the expansion of the company.
Key performance indicators
Year ended Period ended
31 December 2024 31 December 2023
£'000's £'000's
Sales 8,081 5,505
Gross Profit 2,264 1,739
Stock 4,041 3,318
L D Jones
Director
11 July 2025
FLUOROCHEM LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
The directors present their annual report and financial statements for the year ended 31 December 2024.
Principal activities
The principal activity of the company continued to be that of the buying and selling of chemicals.
Results and dividends
The results for the year are set out on page 7.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
L D Jones
D Birch
Research and development
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
Auditor
In accordance with the company's articles, a resolution proposing that Chadwick & Company (Manchester) Limited be reappointed as auditor of the company will be put at a General Meeting.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Strategic report
The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Medium-sized Companies (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of the fair review of the business, principal risks and uncertainties, development and performance and key performance indicators.
FLUOROCHEM LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
L D Jones
Director
11 July 2025
FLUOROCHEM LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF FLUOROCHEM LIMITED
- 4 -
Opinion
We have audited the financial statements of Fluorochem Limited (the 'company') for the year ended 31 December 2024 which comprise the statement of income and retained earnings, the balance sheet and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
FLUOROCHEM LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF FLUOROCHEM LIMITED (CONTINUED)
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Extent to which the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
We considered and updated our knowledge of the company's specific industry and its regulatory environment, and reviewed the company's documentation surrounding the policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management about their own identification and assessment of the risks of irregularities. Based on this understanding, we identified and assessed the risks of material misstatement in the financial statements and designed and performed audit procedures in response to those risks.
We identified the key laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, the most significant of these is the UK Companies Act 2006. We also gained knowledge of the legal and regulatory frameworks which do not have a direct effect on the financial statements but compliance with which may be fundamental to the group's and company's ability to operate or to avoid a material penalty including the following - Control of Substances Hazardous to Health Regulations (COSSH), and The Hazardous Waste (England & Wales) Regulations 2005.
Audit response to risks identified
The audit engagement team were made aware of the potential opportunities and incentives that may exist within the company for fraudulent activity and how and where fraud might occur or be concealed within the financial statements.
FLUOROCHEM LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF FLUOROCHEM LIMITED (CONTINUED)
- 6 -
In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override of controls. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other manual adjustments; assessed whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.
In addition to the above, we designed procedures which included:
enquiring of management and those charged with governance concerning actual and potential litigation and claims and any known instances of non-compliance with laws and regulations, with particular focus on the relevant health and safety laws in relation to the handling of hazardous materials;
assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the company through enquiry or inspection;
reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
performing detailed audit work on areas identified as being susceptible to management bias and override of controls, such as provisions, estimates and journal entries, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of bias;
performing analytical procedures to identify any unusual relationships that may indicate a risk of material misstatement due to fraud.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Tracey Connor BSc FCA
Senior Statutory Auditor
For and on behalf of Chadwick & Company (Manchester) Limited
Chartered Accountants
Statutory Auditors
Capital House
272 Manchester Road
Droylsden
Manchester
M43 6PW
14 July 2025
FLUOROCHEM LIMITED
STATEMENT OF INCOME AND RETAINED EARNINGS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
Year
Period
ended
ended
31 December
31 December
2024
2023
Notes
£
£
Turnover
3
8,081,353
5,505,037
Cost of sales
(5,817,305)
(3,765,562)
Gross profit
2,264,048
1,739,475
Administrative expenses
(3,647,809)
(2,834,730)
Other operating income
439,330
119,422
Operating loss
4
(944,431)
(975,833)
Interest receivable and similar income
7
83,117
63,884
Interest payable and similar expenses
8
(350)
Loss before taxation
(861,314)
(912,299)
Tax on loss
9
231,240
Loss for the financial year
(630,074)
(912,299)
Retained earnings brought forward
9,986,087
11,078,386
Dividends
10
(180,000)
Retained earnings carried forward
9,356,013
9,986,087
The profit and loss account has been prepared on the basis that all operations are continuing operations.
FLUOROCHEM LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 8 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
373,260
401,984
Current assets
Stocks
12
4,040,711
3,318,107
Debtors
13
4,108,211
3,804,163
Cash at bank and in hand
2,159,303
3,232,998
10,308,225
10,355,268
Creditors: amounts falling due within one year
14
(1,325,372)
(771,065)
Net current assets
8,982,853
9,584,203
Net assets
9,356,113
9,986,187
Capital and reserves
Called up share capital
17
100
100
Profit and loss reserves
18
9,356,013
9,986,087
Total equity
9,356,113
9,986,187
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 11 July 2025 and are signed on its behalf by:
L D Jones
Director
Company registration number 02049362 (England and Wales)
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 9 -
1
Accounting policies
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’ – Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ – Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’ – Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of FC 2020 Limited. These consolidated financial statements are available from Companies House.
1.2
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true
1.3
Turnover
The turnover shown in the profit and loss account represents the value of all goods sold during the period, less returns received, at selling price exclusive of Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Research and development expenditure
Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 10 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
15% per annum reducing balance
Fixtures & fittings
20% per annum reducing balance
Motor vehicles
20% per annum reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.7
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.8
Cash at bank and in hand
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 11 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
1.10
Equity instruments
Ordinary shares are classified as equity. There is a single class of Ordinary shares. There are no restrictions on the distribution of dividends or the repayment of capital.
1.11
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 12 -
1.12
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.13
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.14
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.15
Foreign exchange
Transactions denominated in foreign currencies are recorded at the rates of exchange ruling at the dates of the transactions, or at an average rate for the period if the rates do not fluctuate significantly.
Monetary assets and liabilities are translated at year end exchange rates or, where appropriate, at rates of exchange fixed under the terms of the relevant transaction. The resulting exchange rate differences are charged to the profit and loss account.
1.16
Company information
Fluorochem Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 14 Graphite Way, Rossington Park, Hadfield, Derbyshire, SK13 1QH.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
There have been no material judgements, estimates or assumptions concerning the carrying amount of assets and liabilities in the period.
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
3
Turnover and other revenue
An analysis of the company's turnover is as follows:
2024
2023
£
£
Turnover analysed by class of business
Sales generated under the company's principal activity
8,081,353
5,505,037
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
5,647,116
3,521,451
Overseas
2,434,237
1,983,586
8,081,353
5,505,037
2024
2023
£
£
Other revenue
Interest income
83,117
63,884
4
Operating loss
2024
2023
Operating loss for the year is stated after charging:
£
£
Exchange losses
16,993
52,200
Fees payable to the company's auditor for the audit of the company's financial statements
27,500
20,500
Depreciation of owned tangible fixed assets
90,222
68,476
Operating lease charges
75,493
51,981
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Administrative and sales staff
64
65
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Employees
(Continued)
- 14 -
Their aggregate remuneration comprised:
2024
2023
£
£
Wages and salaries
2,157,938
1,574,209
Social security costs
207,027
154,022
Pension costs
44,727
31,949
2,409,692
1,760,180
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
285,175
214,575
Company pension contributions to defined contribution schemes
7,939
6,041
293,114
220,616
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2023 - 1).
Remuneration for qualifying services includes benefits in kind.
Remuneration disclosed above include the following amounts paid to the highest paid director:
2024
2023
£
£
Remuneration for qualifying services
195,367
141,968
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
49,518
63,767
Other interest income
33,599
117
Total income
83,117
63,884
8
Interest payable and similar expenses
2024
2023
£
£
Other interest
350
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
9
Taxation
2024
2023
£
£
Current tax
Adjustments in respect of prior periods
(231,240)
The actual (credit)/charge for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Loss before taxation
(861,314)
(912,299)
Expected tax credit based on the standard rate of corporation tax in the UK of 25.00% (2023: 25.00%)
(215,329)
(228,075)
Unutilised tax losses carried forward
209,062
224,508
Permanent capital allowances in excess of depreciation
4,449
1,519
Depreciation on assets not qualifying for tax allowances
1,818
2,048
Under/(over) provided in prior years
(231,240)
Taxation credit for the year
(231,240)
-
Factors that may affect future tax charges
The company has corporation tax trading losses amounting to £1,501,838 (31/12/2023 - £1,375,740) available to carry forward and relieve against any future years' trading profits it may earn.
10
Dividends
2024
2023
£
£
Interim paid
180,000
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 16 -
11
Tangible fixed assets
Leasehold improvements
Fixtures & fittings
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2024
437,873
1,048,349
16,797
1,503,019
Additions
61,498
61,498
At 31 December 2024
437,873
1,109,847
16,797
1,564,517
Depreciation and impairment
At 1 January 2024
388,382
700,732
11,921
1,101,035
Depreciation charged in the year
7,424
81,823
975
90,222
At 31 December 2024
395,806
782,555
12,896
1,191,257
Carrying amount
At 31 December 2024
42,067
327,292
3,901
373,260
At 31 December 2023
49,491
347,617
4,876
401,984
12
Stocks
2024
2023
£
£
Finished goods and goods for resale
4,040,711
3,318,107
13
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
792,392
1,029,801
Corporation tax recoverable
299,577
Amounts owed by group undertakings
2,878,161
2,009,824
Other debtors
1,203
540
Prepayments and accrued income
436,455
464,421
4,108,211
3,804,163
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 17 -
14
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
724,431
634,674
Amounts owed to group undertakings
29,617
5,691
Taxation and social security
131,333
93,336
Accruals and deferred income
439,991
37,364
1,325,372
771,065
15
Deferred taxation
Deferred tax assets and liabilities are offset where the company has a legally enforceable right to do so.
The company has a deferred tax asset amounting to £296,948 that has not been included in these financial statements. The deferred tax asset consists of the net balance of a deferred tax liability from accelerated capital allowances of £74,433 and a deferred tax asset arising from trading losses carried forward of £371,381.
The directors are of the opinion that it is unlikely that the corporation tax losses will be fully utilised in the next accounting period.
16
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
44,727
31,949
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
17
Share capital
2024
2023
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary shares of £1 each
100
100
18
Reserves
Own shares
Called up share capital represents the nominal value of shares that have been issued.
Profit and loss reserves
Profit and loss reserves includes all current and prior period retained profit and losses.
FLUOROCHEM LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 18 -
19
Financial commitments, guarantees and contingent liabilities
There is an unlimited multilateral guarantee dated 26 February 2021 given by Fluorochem Limited, FC 2020 Limited and FL Holdings (Newco 2) Limited. The bank borrowings of these companies at 31 December 2024 were £1,206,617 (2023 - £1,687,500).
20
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2024
2023
£
£
Within one year
57,500
58,413
Between two and five years
138,958
196,458
196,458
254,871
21
Related party transactions
The company has taken advantage of the exemption under the Financial Reporting Standard 102 Section 33.1A from disclosing any transactions and balances with group entities of which the group owns 100% of the share capital.
Key management personnel are those persons having authority and responsibility for planning, controlling and directing the activities of the company. In the opinion of the board, the key management are the directors of Fluorochem Limited. The compensation of the directors of Fluorochem Limited is disclosed in note 6.
22
Ultimate controlling party
The company is a wholly owned subsidiary of FL Holdings (Newco 2) Limited, a company incorporated in England and Wales.
FL Holdings (Newco 2) Limited is a wholly owned subsidiary of FC 2020 Limited, a company incorporated in England and Wales.
The company is controlled by its directors by virtue of their majority interest in the issued share capital of the ultimate parent company, FC 2020 Limited.
Copies of the consolidated financial statements of the parent company, FC 2020 Limited can be obtained from Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ.
2024-12-312024-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.100L D JonesD BirchD Birch020493622024-01-012024-12-3102049362bus:Director12024-01-012024-12-3102049362bus:CompanySecretaryDirector12024-01-012024-12-3102049362bus:CompanySecretary12024-01-012024-12-3102049362bus:Director22024-01-012024-12-3102049362bus:RegisteredOffice2024-01-012024-12-31020493622024-12-31020493622023-04-012023-12-3102049362core:RetainedEarningsAccumulatedLosses2023-12-3102049362core:RetainedEarningsAccumulatedLosses2023-03-3102049362core:ShareCapital2024-12-3102049362core:ShareCapital2023-12-3102049362core:RetainedEarningsAccumulatedLosses2024-12-3102049362core:RetainedEarningsAccumulatedLosses2023-12-31020493622023-12-3102049362core:ShareCapitalOrdinaryShareClass12024-12-3102049362core:ShareCapitalOrdinaryShareClass12023-12-3102049362core:RetainedEarningsAccumulatedLosses2023-04-012023-12-3102049362core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3102049362core:PlantMachinery2024-12-3102049362core:MotorVehicles2024-12-3102049362core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3102049362core:PlantMachinery2023-12-3102049362core:MotorVehicles2023-12-3102049362core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102049362core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3102049362core:CurrentFinancialInstruments2024-12-3102049362core:CurrentFinancialInstruments2023-12-3102049362core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-01-012024-12-3102049362core:PlantMachinery2024-01-012024-12-3102049362core:MotorVehicles2024-01-012024-12-310204936212024-01-012024-12-310204936212023-04-012023-12-3102049362core:UKTax2024-01-012024-12-3102049362core:UKTax2023-04-012023-12-310204936222024-01-012024-12-310204936222023-04-012023-12-3102049362core:LandBuildingscore:LeasedAssetsHeldAsLessee2023-12-3102049362core:PlantMachinery2023-12-3102049362core:MotorVehicles2023-12-31020493622023-12-3102049362core:WithinOneYear2024-12-3102049362core:WithinOneYear2023-12-3102049362core:BetweenTwoFiveYears2024-12-3102049362core:BetweenTwoFiveYears2023-12-3102049362bus:PrivateLimitedCompanyLtd2024-01-012024-12-3102049362bus:FRS1022024-01-012024-12-3102049362bus:Audited2024-01-012024-12-3102049362bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP